BioSpace unveils its NextGen Bio Class of 2024, spotlighting top US life sciences firms launched between September 2022 and 2023, securing Series A funding. Criteria such as financial strength, partnerships, innovation, and growth potential were used to evaluate these startups. After meticulous assessment, the top 30 were ranked by BioSpace’s editorial team. This esteemed list highlights innovative companies making waves in the industry, promising an exciting future for biotech advancements.
BioSpace is proud to present its NextGen Bio Class of 2024, a list of the hottest new life sciences companies in the United States.
To come up with this list, BioSpace identified companies that launched between September 2022 and September 2023 with Series A funding. They were then assessed using several different criteria including finance, partnerships, pipeline, growth potential and innovation. After awarding points for each category, the BioSpace editorial team ranked its top 30.
The impressive group of startups that make up BioSpace’s NextGen Class of 2024 is already making an impact on the industry. We will continue to keep a close eye on these companies as we move into the new year.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Bio Space
